Skip to main content
PMC home page
AAPS PharmSciTech logoLink to AAPS PharmSciTech
. 2004 Jul 22;5(3):43–50. doi: 10.1208/pt050342

Effect of formulation variables on preparation and evaluation of gelled self-emulsifying drug delivery system (SEDDS) of ketoprofen

Pradeep Patil 1, Prasad Joshi 1, Anant Paradkar 1,✉
PMCID: PMC2750265  PMID: 15760075

Abstract

The purpose of this study was to formulate a gelled self-emulsifying drug delivery system (SEDDS) containing ketoprofen as an intermediate in the development of sustained release solid dosage form. Captex 200 (an oil), Tween 80 (a surfactant), and Capmul MCM (a cosurfactant) were used to formulate SEDDS. Silicon dioxide was used as a gelling agent, which may aid in solidification and retardation of drug release. Effect of concentrations of cosurfactant and gelling agent on emulsification process and in vitro drug diffusion was studied using 32 factorial design. Multiple regression analysis data and response surfaces obtained showed that liquid crystal phase viscosity increased significantly with increasing amount of silicon dioxide, which in turn caused an increase in average droplet size of resultant emulsion and slower drug diffusion. Drug release from the formulation increased with increasing amount of cosurfactant.

Keywords: SEDDS, ketoprofen, gelled SEDDS, silicon dioxide, LC phases

Full Text

The Full Text of this article is available as a PDF (214.0 KB).

References

  • 1.Charman SA, Charman WN, Rogge MC, Wilson TD, Pouton CW. Self-emulsifying drug delivery systems: formulation and biopharmaceutical evaluation of an investigational lipophilic compound. Pharm Res. 1992;9:87–93. doi: 10.1023/A:1018987928936. [DOI] [PubMed] [Google Scholar]
  • 2.Pouton CW. SEDDS: Assessment of the efficiency of emulsification. Int J Pharm. 1985;27:335–348. doi: 10.1016/0378-5173(85)90081-X. [DOI] [Google Scholar]
  • 3.Shah NH, Carvajal MT, Patel CI, Infeld NH, Malick AW. Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int J Pharm. 1994;106:15–23. doi: 10.1016/0378-5173(94)90271-2. [DOI] [Google Scholar]
  • 4.Pouton CW, Charman WN. The potential of oily formulations for drug delivery to the gastro-intestinal tract. Adv Drug Deliv Rev. 1997;25:1–2. doi: 10.1016/S0169-409X(96)00490-5. [DOI] [Google Scholar]
  • 5.Pouton CW. Formulation of self-emulsifying drug delivery systems. Adv Drug Deliv Rev. 1997;25:47–58. doi: 10.1016/S0169-409X(96)00490-5. [DOI] [Google Scholar]
  • 6.ConStantinides PP. Lipid microemulsion for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm Res. 1995;12:1561–1572. doi: 10.1023/A:1016268311867. [DOI] [PubMed] [Google Scholar]
  • 7.Craig DQM, Barker SA, Banning D, Booth SW. An investigation into mechanism of self emulsification using particle size analysis and low frequency dielectric spectroscopy. Int J Pharm. 1995;114:103–110. doi: 10.1016/0378-5173(94)00222-Q. [DOI] [Google Scholar]
  • 8.Porter CJ, Charman WN. In vitro assessment of oral lipid based formulations. Adv Drug Deliv Rev. 2001;50(suppl 1):S127–S147. doi: 10.1016/S0169-409X(01)00182-X. [DOI] [PubMed] [Google Scholar]
  • 9.Itoh K, Tozuka Y, Oguchi T, Yamamoto K. Improvement of physicochemical properties of N-4472 part I formulation design by using selfmicroemulsifying system. Int J Pharm. 2002;238:153–160. doi: 10.1016/s0378-5173(02)00085-6. [DOI] [PubMed] [Google Scholar]
  • 10.Kim H-J, Yoon KA, Hahn M, Park E-S, Chi S-C. Preparation and in vitro evaluation of self-microemulsifying drug delivery systems containing idebenone. Drug Dev Ind Pharm. 2000;26:523–529. doi: 10.1081/DDC-100101263. [DOI] [PubMed] [Google Scholar]
  • 11.Kommuru TR, Gurley B, Khan MA, Reddy IK. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int J Pharm. 2001;212:233–246. doi: 10.1016/S0378-5173(00)00614-1. [DOI] [PubMed] [Google Scholar]
  • 12.Julianto T, Yuen KH, Noor AM. Improved bioavailability of vitamin E with a self emulsifying formulation. Int J Pharm. 2000;200:53–57. doi: 10.1016/S0378-5173(00)00337-9. [DOI] [PubMed] [Google Scholar]
  • 13.Khoo S-H, Humberstone AJ, Porter CJH, Edwards GA, Charman WN. Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine. Int J Pharm. 1998;167:155–164. doi: 10.1016/S0378-5173(98)00054-4. [DOI] [Google Scholar]
  • 14.Gao Z-G, Choi H-G, Shin H-J, et al. Physicochemical characterization and evaluation of a microemulsion system for oral delivery of cyclosporine A. Int J Pharm. 1998;161:75–86. doi: 10.1016/S0378-5173(97)00325-6. [DOI] [Google Scholar]
  • 15.Kim JY, Ku YS. Enhanced absorption of indomethacin after oral or rectal administration of a self-emulsifying system containing indomethacin to rats. Int J Pharm. 2000;194:81–89. doi: 10.1016/S0378-5173(99)00367-1. [DOI] [PubMed] [Google Scholar]
  • 16.Vergote GJ, Vervaet C, Van Driessche I, et al. An oral controlled release matrix pellet formulation containing nanocrystalline ketoprofen. Int J Pharm. 2001;219:81–87. doi: 10.1016/S0378-5173(01)00628-7. [DOI] [PubMed] [Google Scholar]
  • 17.Yamada T, Onishi H, Machida Y. Sustained release ketoprofen microparticles with ethylcellulose and carboxymethylethylcellulose. J Control Release. 2001;75:271–282. doi: 10.1016/S0168-3659(01)00399-6. [DOI] [PubMed] [Google Scholar]
  • 18.Roda A, Sabatini L, Mirasoli M, Baraldini M, Roda E. Bioavailability of a new ketoprofen formulation for once-daily oral administration. Int J Pharm. 2002;241:165–172. doi: 10.1016/S0378-5173(02)00230-2. [DOI] [PubMed] [Google Scholar]
  • 19.El-Kamel AH, Sokar MS, Al Gamal SS, Naggar VF. Preparation and evaluation of ketoprofen floating oral delivery system. Int J Pharm. 2001;220:13–21. doi: 10.1016/S0378-5173(01)00574-9. [DOI] [PubMed] [Google Scholar]
  • 20.Rhee Y-S, Choi J-G, Park E-S, Chi S-C. Transdermal delivery of ketoprofen using microemulsions. Int J Pharm. 2001;228:161–170. doi: 10.1016/S0378-5173(01)00827-4. [DOI] [PubMed] [Google Scholar]
  • 21.Nazzal S, Smalyukh II, Lavrentovich OD, Khan MA. Preparation and in vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion formation. Int J Pharm. 2002;235:247–265. doi: 10.1016/S0378-5173(02)00003-0. [DOI] [PubMed] [Google Scholar]
  • 22.Attama AA, Nzekwe IT, Nnamani PO, Adikwu MU, Onugu CO. The use of solid self-emulsifying systems in the delivery of diclofenac. Int J Pharm. 2003;262:23–28. doi: 10.1016/S0378-5173(03)00315-6. [DOI] [PubMed] [Google Scholar]
  • 23.Newton M, Petersson J, Podczeck F, Clarke A, Booth S. The influence of formulation variables on the properties of pellets containing a self-emulsifying mixture. J Pharm Sci. 2001;90:987–995. doi: 10.1002/jps.1051. [DOI] [PubMed] [Google Scholar]
  • 24.Schwarz J. Solid self-emulsifying dosage form for improved delivery of poorly soluble hydrophobic compounds and the process of preparation thereof. US patent application No. 2003 0 072 789. 2003.
  • 25.Raghavan SR, Hou J, Baker GL, Khan SA. Colloidal interactions between particles with tethered nonpolar chains dispersed in polar media: direct correlation between dynamic rheology and interaction parameters. Langmuir. 2000;16:1066–1077. doi: 10.1021/la9815953. [DOI] [Google Scholar]
  • 26.Raghavan SR, Walls HJ, Khan SA. Rheology of silica dispersions in organic liquids: new evidence for solvation forces dictated by hydrogen bonding. Langmuir. 2000;16:7920–7930. doi: 10.1021/la991548q. [DOI] [Google Scholar]
  • 27.Schott H. Remington's Pharmaceutical Sciences. 18th ed. Easton, PA: Mack Publishing Co; 1990. Rheology; pp. 310–326. [Google Scholar]

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists

RESOURCES